(Q34090967)

30 July 2017

1 reference

title

Novel chemotherapeutic agents for the treatment of brain cancer (English)

1 reference

30 July 2017

1 reference

1 reference

Newton HB

1

1 reference

PubMed ID

11093355

30 July 2017

language of work or name

English

0 references

publication date

1 December 2000

1 reference

Expert Opinion on Investigational Drugs

30 July 2017

1 reference

30 July 2017

9

1 reference

30 July 2017

12

1 reference

30 July 2017

2815-2829

1 reference

Primary central nervous system tumors: advances in knowledge and treatment

30 July 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2815

Clinical presentation, diagnosis, and pharmacotherapy of patients with primary brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2815

Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2815

From triazines and triazenes to temozolomide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2815

Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2815

Depletion of O6-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2815

Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2815

Phase I study of temozolomide in paediatric patients with advanced cancer. United Kingdom Children's Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2815

Glioma invasion in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2815

Adhesion molecules and malignant gliomas: implications for tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2815

Cell adhesion molecules: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2815

Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2815

Clinical potential of matrix metalloprotease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2815

Matrix metalloproteinase inhibitors: applications in oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2815

New drugs on the horizon: matrix metalloproteinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2815

Preclinical and clinical studies of MMP inhibitors in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2815

Marimastat (BB2516): current status of development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2815

Expression of matrix metalloproteinases in human glioma cell lines in the presence of IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2815

Effect of synthetic matrix-metalloproteinase inhibitors on invasive capacity and proliferation of human malignant gliomas in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2815

The current status of camptothecin analogues as antitumor agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2815

Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against pediatric and adult central nervous system tumor xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2815

Enhancement of irinotecan (CPT-11) activity against central nervous system tumor xenografts by alkylating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2815

Schedule-dependent activity of irinotecan plus BCNU against malignant glioma xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2815

Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2815

Mechanisms of angiogenesis in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2815

Angiogenesis in brain tumors; pathobiological and clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2815

Antiangiogenic therapy in brain tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2815

The effect of the anti-angiogenic agent TNP-470 on tumor growth and vascularity in low passaged xenografts of human gliomas in nude mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2815

Suramin treatment of human glioma xenografts; effects on tumor vasculature and oxygenation status

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2815

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2815

Proliferation, migration and invasion of human glioma cells exposed to paclitaxel (Taxol) in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2815

Cytotoxicity and cell-cycle effects of paclitaxel when used as a single agent and in combination with ionizing radiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2815

Paclitaxel disposition in plasma and central nervous systems of humans and rats with brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2815

Infections and human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2815

Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2815

10.1517/13543784.9.12.2815

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

11093355